Vitamin D3 lactam derivative

Details for Australian Patent Application No. 2004285813 (hide)

Owner Teijin Pharma Limited

Inventors Hashimoto, Yuichi; Kato, Yuko; Nagasawa, Kazuo

Agent Davies Collison Cave

Pub. Number AU-B-2004285813

PCT Pub. Number WO2005/042482

Priority 60/516,727 04.11.03 US

Filing date 4 November 2004

Wipo publication date 12 May 2005

Acceptance publication date 8 October 2009

International Classifications

A61K 31/593 (2006.01)

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

C07D 207/273 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042482 Priority application(s): WO2005/042482

8 October 2009 Application Accepted

  Published as AU-B-2004285813

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285831-Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents

2004285811-2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis